These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30153883)

  • 1. Interconnected clusters of invasive meningococcal disease due to
    Miglietta A; Fazio C; Neri A; Pezzotti P; Innocenti F; Azzari C; Rossolini GM; Moriondo M; Nieddu F; Iannazzo S; D'Ancona F; Maraglino FP; Guerra R; Rezza G; Voller F; Stefanelli P
    Euro Surveill; 2018 Aug; 23(34):. PubMed ID: 30153883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carriage rates and risk factors during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11) in Tuscany, Italy: a cross-sectional study.
    Miglietta A; Innocenti F; Pezzotti P; Riccobono E; Moriondo M; Pecile P; Nieddu F; Rossolini GM; Azzari C; ; Balocchini E; Rezza G; Voller F; Stefanelli P
    BMC Infect Dis; 2019 Jan; 19(1):29. PubMed ID: 30621624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy.
    Pezzotti P; Miglietta A; Neri A; Fazio C; Vacca P; Voller F; Rezza G; Stefanelli P
    Vaccine; 2018 Jul; 36(29):4222-4227. PubMed ID: 29895504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of invasive meningococcal disease of serogroup C / clonal complex 11, Tuscany, Italy, 2015 to 2016.
    Stefanelli P; Miglietta A; Pezzotti P; Fazio C; Neri A; Vacca P; Voller F; D'Ancona FP; Guerra R; Iannazzo S; Pompa MG; Rezza G
    Euro Surveill; 2016; 21(12):. PubMed ID: 27035155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serogroup C
    Findlow H; Campbell H; Lucidarme J; Andrews N; Linley E; Ladhani S; Borrow R
    Euro Surveill; 2019 Jan; 24(1):. PubMed ID: 30621818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-based study of a spatio-temporal cluster of invasive meningococcal disease due to Neisseria meningitidis serogroup C, clonal complex 11.
    Stefanelli P; Fazio C; Neri A; Ciammaruconi A; Balocchini E; Anselmo A; Azzari C; Rossolini GM; Vacca P; Fortunato A; Palozzi A; Fillo S; Lista F; Moriondo M; Nieddu F; Rezza G
    J Infect; 2016 Aug; 73(2):136-44. PubMed ID: 27235364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive Meningococcal Disease due to group C N. meningitidis ST11 (cc11): The Tuscany cluster 2015-2016.
    Menichetti F; Fortunato S; Ricci A; Salani F; Ripoli A; Tascini C; Fusco FM; Mencarini J; Bartoloni A; Di Pietro M
    Vaccine; 2018 Sep; 36(40):5962-5966. PubMed ID: 30172636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive vaccination as control strategy for an outbreak of invasive meningococcal disease caused by
    Fazio C; Daprai L; Neri A; Tirani M; Vacca P; Arghittu M; Ambrosio L; Cereda D; Gramegna M; Palmieri A; Carannante A; Bertoli MR; Crottogini L; Gennati G; Quinz E; Trezzi L; Ciammaruconi A; Fillo S; Fortunato A; Rezza G; Lista F; Stefanelli P
    Euro Surveill; 2022 Jun; 27(24):. PubMed ID: 35713021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serogroup C invasive meningococcal disease among men who have sex with men and in gay-oriented social venues in the Paris region: July 2013 to December 2014.
    Aubert L; Taha M; Boo N; Le Strat Y; Deghmane AE; Sanna A; Barret AS; Lévy-Bruhl D; Vandentorren S; Parent du Châtelet I
    Euro Surveill; 2015 Jan; 20(3):. PubMed ID: 25635319
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of meningococcal C conjugate vaccination four years after introduction of routine childhood immunization in Brazil.
    Andrade AL; Minamisava R; Tomich LM; Lemos AP; Gorla MC; de Cunto Brandileone MC; Domingues CMS; de Moraes C; Policena G; Bierrenbach AL;
    Vaccine; 2017 Apr; 35(16):2025-2033. PubMed ID: 28318769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage.
    Lucidarme J; Hill DM; Bratcher HB; Gray SJ; du Plessis M; Tsang RS; Vazquez JA; Taha MK; Ceyhan M; Efron AM; Gorla MC; Findlow J; Jolley KA; Maiden MC; Borrow R
    J Infect; 2015 Nov; 71(5):544-52. PubMed ID: 26226598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cgMLST characterisation of invasive Neisseria meningitidis serogroup C and W strains associated with increasing disease incidence in the Republic of Ireland.
    Mulhall RM; Bennett DE; Bratcher HB; Jolley KA; Bray JE; O'Lorcain PP; Cotter SM; Maiden MCJ; Cunney RJ
    PLoS One; 2019; 14(5):e0216771. PubMed ID: 31141820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimates of the reproductive numbers and demographic reconstruction of outbreak associated with C:P1.5-1,10-8:F3-6:ST-11(cc11) Neisseria meningitidis strains.
    Lo Presti A; Vacca P; Neri A; Fazio C; Ambrosio L; Rezza G; Stefanelli P
    Infect Genet Evol; 2020 Oct; 84():104360. PubMed ID: 32407793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a temporary vaccination recommendation in response to an outbreak of invasive meningococcal serogroup C disease in men who have sex with men in Berlin, 2013-2014.
    Koch J; Hellenbrand W; Schink S; Wichmann O; Carganico A; Drewes J; Kruspe M; Suckau M; Claus H; Marcus U
    Euro Surveill; 2016; 21(5):12-22. PubMed ID: 26877165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the effect of targeted strategies as control tools for hypervirulent meningococcal C outbreaks: a case study from Tuscany, Italy, 2015 to 2016.
    Guzzetta G; Ajelli M; Miglietta A; Fazio C; Neri A; Merler S; Rezza G; Stefanelli P
    Euro Surveill; 2023 May; 28(19):. PubMed ID: 37166763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013.
    Tsang RS; Hoang L; Tyrrell G; Horsman G; Wylie J; Jamieson FB; Lefebvre B; Taha MK
    J Med Microbiol; 2015 Feb; 64(Pt 2):174-9. PubMed ID: 25627205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of meningococcal C conjugate vaccination campaign in Emilia-Romagna, Italy.
    Pascucci MG; Di Gregori V; Frasca G; Rucci P; Finarelli AC; Moschella L; Borrini BM; Cavrini F; Liguori G; Sambri V; Bonanni P; Fantini MP
    Hum Vaccin Immunother; 2014; 10(3):671-6. PubMed ID: 24384537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
    Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
    Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular surveillance of brazilian meningococcal isolates serogroup c in the pre and post-men-c-vaccination period: Emergence of ST-3780.
    Azevedo AC; Franco NEC; de Carvalho Rocha MR; Andrade C; Torres MC; de Filippis I
    Infect Genet Evol; 2020 Mar; 78():104079. PubMed ID: 31669441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serogroup C meningococci in Italy in the era of conjugate menC vaccination.
    Stefanelli P; Fazio C; Sofia T; Neri A; Mastrantonio P
    BMC Infect Dis; 2009 Aug; 9():135. PubMed ID: 19698137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.